Previous Article | Next Article ![]()
Infection and Immunity, December 1999, p. 6424-6433, Vol. 67, No. 12
Center for Vaccine Development,
Received 6 July 1999/Returned for modification 20 August
1999/Accepted 24 September 1999
The broad objective of the research presented here is to develop a
noncatalytic plasmid maintenance system for the stabilization of
multicopy expression plasmids encoding foreign antigens in a
Salmonella typhi live-vector vaccine strain such as CVD
908-htrA. We have enhanced the maintenance of expression
plasmids at two independent levels. First, we removed dependence upon
balanced-lethal maintenance systems that involve catalytic enzymes
expressed from multicopy plasmids; we accomplished this through
incorporation into expression plasmids of a postsegregational killing
system based on the noncatalytic hok-sok plasmid addiction
system from the antibiotic resistance factor pR1. We also included at
least one naturally occurring plasmid partition function in our
expression plasmids, which eliminates random segregation of these
plasmids, thereby enhancing their inheritance and stability; to
accomplish this, we incorporated either the par locus from
pSC101, the parA locus from pR1, or both. We monitored the
stability of optimized expression plasmids within CVD
908-htrA by quantitating expression of a variant of green
fluorescent protein (GFPuv) by using flow cytometry. In this report, we
demonstrate the utility of this novel plasmid maintenance system in
enhancing the stability of our expression plasmids and go on to show
that as the copy number of stabilized plasmids increases, the toxicity
of GFPuv synthesis also increases. The implications of these
observations for the rational design of immunogenic and protective
bacterial live vector vaccines are discussed.
Bacterial live-vector vaccines
represent a vaccine development strategy that offers exceptional
flexibility. In this approach, genes that encode protective antigens of
unrelated bacterial, viral, or parasitic pathogens are expressed in a
live vector that carries the foreign antigens to the immune system,
thereby eliciting an appropriate immune response. The attenuated
Salmonella typhi vaccine strain CVD 908-htrA is a
particularly attractive live vector in that it is well tolerated and
elicits a broad immune response to S. typhi antigens, which
includes intestinal soluble immunoglobulin A antibodies, serum
immunoglobulin G antibodies, and cellular immune responses (47,
48). In addition, genetic methods have been developed to express
foreign antigens within attenuated S. typhi vaccine strains,
and a murine intranasal model has been developed as a practical animal
model for examining the immunogenicity and protective efficacy of a
wide variety of heterologous antigens within S. typhi-based
live-vector vaccines, prior to initiating clinical trials (3,
16).
The efficacy of any bacterial live-vector vaccine rests with its
ability to present sufficient foreign antigen to the human immune
system to initiate the desired protective immune response. Controlled
expression of heterologous antigens from multicopy expression plasmids
represents one obvious solution for synthesis of high levels of antigen
within live vectors. However, these plasmids may become unstable in
vivo, resulting in the loss of foreign genes and a decrease in the
intended immune response.
One method of enhancing the inheritance of expression plasmids by live
vectors involves construction of a "balanced-lethal" system for
plasmids expressing heterologous antigens (34). In a
plasmid-based balanced-lethal system, plasmids replicating in the
cytoplasm of the bacterium express a critical protein required by the
bacterium to grow and replicate; loss of such plasmids removes the
ability of the bacterium to express the critical protein and results in
cell death. This phenomenon of plasmid loss during bacterial
replication, which results in the death of any plasmidless bacterium,
is also referred to as "postsegregational killing." Such a system
has been successfully employed in Salmonella typhimurium and
is based on expression of the asd gene encoding aspartate Here, we present the design and initial testing of a novel set of
isogenic multicopy expression plasmids into which we have incorporated
a noncatalytic postsegregational killing function, coupled with both
active (14, 27) and passive plasmid partition functions
(1, 31, 54), to provide a plasmid maintenance system
designed to optimize expression of heterologous antigens within CVD
908-htrA for delivery to the human immune system. Since this
method of improving plasmid maintenance involves no chromosomal mutagenesis of the live vector strain, in principle, such stabilized plasmids can be introduced into any live vector strain to improve the
immunogenicity of heterologous antigens expressed, without additional
genetic manipulations.
The approach is based on the use of the naturally occurring
hok-sok postsegregational killing system residing on the R
factor pR1 (19, 20). The hok-sok system is a
two-component toxin-antitoxin system in which hok encodes a
lethal pore-forming Hok protein. Synthesis of Hok is blocked by
hybridization of a small antisense sok mRNA to
hok mRNA, preventing translation and synthesis of Hok.
However, sok mRNA is highly susceptible to degradation by nucleases, and its protective intracellular concentration must be
maintained by constitutive transcription from resident plasmids carrying hok-sok. Therefore, bacteria that spontaneously
lose such plasmids are postsegregationally killed because existing levels of the protective sok mRNA rapidly drop and levels of
the more stable toxin-encoding hok mRNA quickly lead to Hok
synthesis and cell death.
Inheritance of these expression plasmids has been enhanced through
insertion of at least one partition function. A passive par
locus from pSC101 (4, 31, 32, 52) was tested, in which no de
novo partitioning proteins were encoded. In addition, the
parA centromere-like active partitioning system from pR1
(14, 27) was investigated, since the combination of
hok-sok and parA naturally occurs within pR1 and
was not expected to present any compatibility complications. Plasmid
maintenance was monitored by using flow cytometry to measure synthesis
of a variant green fluorescent protein (GFPuv) test antigen within
plasmid-bearing CVD 908-htrA. We show that although
individual maintenance functions contribute to various degrees to the
observed stability of expression plasmids, the highest levels of
sustained synthesis of the test heterologous antigen GFPuv were
detected from expression plasmids carrying the full complement of
maintenance functions.
Bacterial strains and culture conditions.
All plasmid
constructions were recovered in Escherichia coli DH5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Optimization of Plasmid Maintenance in the
Attenuated Live Vector Vaccine Strain Salmonella typhi
CVD 908-htrA

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-semialdehyde dehydrogenase (Asd) (15, 34). Asd is a
critical enzyme involved in the synthesis of structural components
essential for the formation of the cell wall in gram-negative bacteria. Therefore, loss of plasmids encoding such a critical enzyme would be
lethal for any bacterium incapable of synthesizing Asd from the
chromosome. Although the asd balanced-lethal system has been successfully employed in attenuated S. typhimurium-based
live-vector strains for immunization of mice with a variety of
prokaryotic and eukaryotic antigens (12, 28, 45), use of
this method for stabilizing plasmids within attenuated S. typhi vaccine strains has, to date, been unsuccessful
(47).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(Gibco BRL). Construction of the hok-sok gene cassette used pR1 template DNA isolated from E. coli J53(pR1), a generous
gift from James B. Kaper. The live vector S. typhi CVD
908-htrA is an auxotrophic derivative of the wild-type
strain Ty2 with deletions in aroC, aroD, and
htrA (48). All strains used in this work were
grown in media supplemented with 2,3-dihydroxybenzoic acid (DHB) as
previously described (16, 26). When grown on solid medium,
plasmid-bearing strains of CVD 908-htrA were streaked from
frozen (
70°C) master stocks onto 2× Luria-Bertani (LB) agar containing 20 g of Bacto Tryptone, 10 g of Bacto yeast
extract, and 50 mM NaCl (2× LB agar) plus carbenicillin at a
concentration of 50 µg/ml. Plates were incubated at 30°C for 24 to
36 h to obtain isolated colonies ~2 mm in diameter; strains were
incubated at 30°C to minimize the toxicity of GFPuv expression in CVD
908-htrA.
Molecular genetic techniques.
Standard techniques were used
for the construction of the plasmids represented here (42).
Unless otherwise noted, native Taq DNA polymerase (Gibco
BRL) was used in PCRs. S. typhi strains were prepared for
electroporation of recombinant plasmids after being harvested from
Miller's LB broth (Gibco BRL) supplemented with DHB; after pelleting
of bacteria, the cells were washed three times with one culture volume
of sterile distilled water and resuspended in sterile distilled water
to a final volume of 1/100 of the original culture volume.
Electroporation of strains was performed in a Gene Pulser apparatus
(Bio-Rad) set at 2.5 kV, 200
, and 25 µF. Following
electroporation, bacteria were repaired with SOC medium (Biofluids) and
incubation at 37°C and 250 rpm for 45 min; bacteria were then plated
on 1× LB medium containing DHB plus 50 µg of carbenicillin per ml,
and incubated at 30°C for 24 h. Isolated colonies were then
swabbed onto supplemented 2× LB medium and incubated at 30°C for
16 h. Frozen master stocks were prepared by harvesting bacteria
into SOC medium without further supplementation and freezing at
70°C.
Construction of expression plasmids. (i) Construction of pJN1 and
pJN2.
All primers used in this work are listed in Table
1; essential plasmids created from these
primers are listed in Table 2 to
illustrate the flow of logic in designing the final isogenic expression
plasmids. The expression plasmids constructed for these studies are
composed of three basic cassettes encoding (i) expression of a
heterologous antigen, (ii) a plasmid origin of replication, and (iii)
selection and maintenance functions. To accomplish this, a basic
replicon was constructed in which these cassettes were separated by
unique restriction sites. pTETnir15 (Table 2)
(38) was reengineered such that the oriE1 origin
of replication and bla gene were separated by a unique
SpeI site. Toward this end, an oriE1 cassette was
synthesized by PCR with Vent polymerase with primers 1 and 2 and
pCVD315 (17) as the template. The resulting 735-bp fragment
carries engineered SpeI and BglII sites 5'
proximal to the promoter controlling transcription of RNA II, and an
engineered AvrII site 675 bases from these sites. A separate
PCR was carried out by using primers 3 and 4 to create a 1,234-bp
bla cassette containing an engineered XbaI site
5' proximal to the original EcoRI site. The products from
these two PCRs were gel purified and used in an overlapping PCR with
primers 1 and 4 to yield a final 1,916-bp
oriE1-bla fragment which was self-ligated to
create pJN1. The Pnir15-toxC fragment
from pTETnir15 was excised as an EcoRI (partial
digestion)-AvaI fragment, in which the AvaI terminus was polished, and inserted into the multiple cloning region
from pSL1180 (9) cleaved with EcoRI and
StuI; this cassette was then reexcised as an
EcoRI (partial digestion)-AvrII fragment and
inserted into pJN1 cleaved with EcoRI-AvrII,
creating pJN2 (Table 2).
|
|
(ii) Construction of pGFPompC.
To facilitate screening
of a functional osmotically regulated PompC
allele from E. coli, an aphA-2 cassette was
constructed, encoding resistance to the aminoglycosides neomycin and
kanamycin (44). A PCR was carried out with primers 5 and 6 with the template pIB279 (5) to generate a 1,044-bp product,
from which a promoterless 903-bp aphA-2
BglII-NheI fragment was cleaved for replacement of a
BglII-NheI toxC cassette encoding
fragment C of tetanus toxin in pTETnir15. The anaerobically
regulated Pnir15 promoter was replaced with a
459-bp EcoRI-BglII PompC
allele constructed with primers 7 and 8 with chromosomal template DNA
from E. coli DH5
to create pKompC. After
confirming osmotic induction of PompC by
examining the increase in resistance to kanamycin with increasing osmolarity, the aphA-2 cassette was then replaced with a
gfpuv gene encoding a prokaryotic codon-optimized GFPuv
allele (Clontech) (13). The gfpuv gene was
recovered by PCR with primers 9 and 10 with the template pGFPuv to
generate a 751-bp BglII-NheI fragment, which was
inserted into pKompC, to generate pGFPompC.
Colonies were screened for functional GFPuv, and the brightest colonies were then examined for induction of fluorescence with increasing concentrations of NaCl. A PompC1-gfpuv cassette
(see Results below) was cleaved from pGFPompC1 as an
EcoRI-NheI fragment and inserted into a
derivative of pJN2 cleaved with EcoRI-NheI to
create pJJ4.
(iii) Construction of pNRB1, pGEN2, and pGEN3. Since it was intended that copy number not be influenced by transcription originating from promoters outside the origin of replication, it was necessary to ensure that all replication cassettes were flanked at both ends by transcription terminators. Because the origin and antigen cassettes of pJN2 are separated by the trpA terminator, it was only necessary to insert one additional terminator between the origin and bla cassettes.
To facilitate construction of additional plasmids later on, a tetA-T1T2 cassette was created. pYA292 (15) was first cleaved with HindIII and BglII, and the T1T2 terminator fragment was polished and inserted into the SmaI site of the pBluescript II KS (Stratagene) multiple cloning region; when the proper orientation was identified, this cassette was reexcised as a BamHI-PstI fragment and inserted into pIB307 (5) cleaved with BamHI-PstI, creating pJG14. It was later determined by sequence analysis that the cassette had undergone a deletion of approximately 100 bp, removing half of the T2 terminator. Using pBR322 as a template, primers 11 and 12 were used to synthesize a 1,291-bp tetA BglII fragment. This tetA BglII fragment was then inserted into the BamHI site of pJG14, such that transcription of the tetA gene is terminated at the T1T2 terminator, creating pJG14tetA. Finally, this tetA-T1T2 cassette was cleaved from pJG14tetA as an EcoRI-PstI fragment in which the PstI site was removed by polishing; the resulting fragment was inserted into pJJ4 cleaved with SpeI, polished, and recleaved with EcoRI to replace the bla cassette and create pNRB1. The noncatalytic postsegregational killing function to be incorporated into the plasmid maintenance systems of the expression plasmids described here was the hok-sok locus, from the multiple drug resistance R factor pR1. Initial attempts at recovering the hok-sok locus after PCR were unsuccessful. It was therefore necessary to use overlapping PCR to generate a cassette in which hok-sok was transcriptionally fused to a promoterless tetA gene such that transcription originating from the hok promoter would continue into tetA and result in a transcript encoding both Hok and resistance to tetracycline. pR1 plasmid DNA was purified from E. coli J53(pR1) in which pR1 encodes resistance to both carbenicillin and chloramphenicol. A 640-bp hok-sok fragment was synthesized by using primers 13 and 14; a promoterless 1,245-bp tetA fragment was recovered in a separate PCR by using primers 15 and 12 with pNRB1 as the template. The products from these two PCRs were then used in an overlapping PCR with primers 12 and 13 to yield the final 1,816-bp hok-sok-tetA fragment. This fragment was inserted as an EcoRI-SphI fragment into pNRB1 cleaved with EcoRI-SphI, regenerating the tetA gene and creating pGEN1. Two isogenic plasmids were then constructed, differing only in copy number, from which all further expression plasmids would be derived. The BglII-AvrII origin of replication cassette of pGEN1 was replaced by a BglII-AvrII oriE1 cassette from pJN2 to generate pGEN2. In addition, an ori15A replication cassette was synthesized by PCR by using primers 16 and 17 with pACYC184 template to generate a 629-bp BamHI-AvrII fragment, which was inserted into pGEN2 cleaved with BglII-AvrII to create pGEN3.(iv) Construction of pJN5, pGEN51, and pGEN91. The principle set of isogenic expression plasmids, to which individual elements of a plasmid maintenance system were sequentially added, was composed of pGEN51 (containing oriE1) and pGEN91 (containing ori15A). The basic replicon from which these two plasmids were constructed was pJN5, which was assembled by cleaving the PompC-gfpuv cartridge as an EcoRI-NheI fragment from pGFPompC to replace the Pnir15-toxC cassette of pJN2. Construction of pGEN51 was then accomplished by removal of the replication cassette from pGEN2 as a BamHI fragment and replacement of the origin of replication within pJN5 digested with BglII and BamHI, thereby regenerating the gfpuv gene. Construction of pGEN91 was accomplished in an identical manner by excision of the origin cassette from pGEN3 as a BamHI fragment and insertion into pJN5 (Fig. 1 and Table 2).
|
(v) Construction of pJN6, pGEN71, and pGEN111. The hok-sok locus was then excised as an XbaI-SalI fragment from pGEN2 and inserted into pJN5 cleaved with XbaI and SalI, again regenerating the gfpuv gene to create pJN6. Construction of pGEN71 and pGEN111 was then carried out exactly as described for pGEN51 and pGEN91 by insertion into pJN6 of origin cassettes as BamHI fragments from pGEN2 and pGEN3, respectively (Fig. 1 and Table 2).
(vi) Construction of pJN7, pGEN84, and pGEN121. Construction of oriE1 and ori15A expression plasmids containing a plasmid maintenance system, composed of both a postsegregational killing system and at least one partition function, was first attempted by using the par function from pSC101. A 377-bp BamHI-BglII fragment was synthesized with primers 18 and 19 with pSC101 template DNA; this fragment was inserted into pJN6 cleaved with BglII to create pJN7. As in the constructions above, origin cassettes from pGEN2 and pGEN3 were then excised as BamHI fragments and inserted into pJN7 digested with BglII and BamHI to create pGEN84 and pGEN121.
(vii) Construction of pJN8, pGEN183, pGEN193, pGEN211, and pGEN222. The final expression plasmids were constructed by introduction of the parA active partitioning locus from pR1. As with hok-sok, initial attempts at recovering the parA locus after PCR were unsuccessful. It was necessary to use overlapping PCR to generate an aphA-2-parA cassette, in which aphA-2 and parA were divergently transcribed and separated by XbaI and XhoI sites, to enable subcloning of the parA locus. A 1,737-bp parA fragment was synthesized by using primers 20 and 21 with pR1 template; a 1,076-bp aphA-2 fragment was recovered in a separate PCR by using primers 22 and 23 with pIB279 as the template. The products from these two PCRs were then used in an overlapping PCR with primers 21 and 23 to yield the final 2,743-bp aphA-2-parA fragment. This fragment was inserted as a 2,703-bp EcoRI-SpeI fragment into pJN6. The parA cassette was then reexcised as an XhoI fragment and inserted again into pJN6 cleaved with XhoI, regenerating the gfpuv gene and creating pJN8.
Plasmids carrying a plasmid maintenance system, composed of the postsegregational killing hok-sok function and parA, were constructed by excision of oriE1 and ori15A BamHI-SpeI cassettes from pGEN51 and pGEN91, respectively, and insertion into pJN8 cleaved with BamHI and SpeI, regenerating gfpuv and creating pGEN183 and pGEN193, respectively. Plasmids containing the full complement of hok-sok, par, and parA maintenance functions were constructed by insertion of par-containing origin cassettes as BamHI-SpeI cassettes from pGEN84 and pGEN121 into pJN8 cleaved with BamHI and SpeI, again regenerating gfpuv to create pGEN211 and pGEN222, respectively.Flow cytometry.
Quantitation of GFPuv and plasmid
maintenance were analyzed by measuring the fluorescence of
plasmid-bearing live vectors by using an Epics Elite ESP flow
cytometer/cell sorter system (Coulter) with the argon laser exciting
bacteria at 488 nm and emissions detected at 525 nm.
Twenty-five-milliliter 1× LB cultures grown as described above were
pelleted, and bacteria were resuspended in 1 ml of PBS. Cells were then
diluted 1:1,000 in PBS prior to determination of viable counts and flow
analysis. Forward versus side light scatter, measured with logarithmic
amplifiers, was used to gate on bacteria. A minimum of 30,000 events
were acquired from each sample at a collection rate of approximately
3,500 events per second. Mean fluorescence intensity for a given
bacterial population was determined by using the Epics Elite Software
Analysis Package. The fluorescence for plasmidless S. typhi
CVD 908-htrA and E. coli DH5
strains was
quantitated to establish that autofluorescence from either host strain
was negligible and that fluorescence measured for plasmid-bearing
strains was directly related to synthesis of GFPuv.
| |
RESULTS |
|---|
|
|
|---|
Rationale for construction of the expression plasmids. Although balanced-lethal plasmid stabilization systems based on expression of Asd have been created to maintain plasmids within Salmonella, a potential limitation of the asd system is its reliance on synthesis of an enzyme with catalytic activity. Since complementation with only a single copy of asd is sufficient to remove auxotrophy (15), it is not clear why all copies of a multicopy expression plasmid should remain stable and maintain maximum gene dosage, especially if they encode an especially problematic antigen which inhibits growth of the bacterium. Another potential limitation of the asd system is that it does not enhance the inheritance of resident plasmids, which continue to segregate randomly with or without the presence of the asd system. Therefore, if resident expression plasmids carrying asd genes are inherently unstable for some undetermined reason, they will be lost regardless of the requirement of the bacterium for Asd. Here, we present the design and initial testing of a set of isogenic multicopy expression plasmids into which we have incorporated a noncatalytic postsegregational killing function, coupled with both active (14, 27) and passive plasmid partition functions (1, 31, 54), to provide a plasmid maintenance system designed to optimize expression of heterologous antigens within CVD 908-htrA for delivery to the human immune system.
Two series of isogenic expression plasmids were constructed for use in E. coli and Salmonella, with expected copy numbers of ~60 copies per chromosomal equivalent (from pAT153, carrying a derivative of oriE1 [11, 38, 50]) or ~15 copies per equivalent (derived from pACYC184 and carrying ori15A [10, 25]). Each plasmid comprises three basic cassettes encoding the origin of replication; a plasmid selection cassette encoding
-lactamase, which confers
resistance to carbenicillin; and a heterologous antigen expression
cassette. A representative set of expression plasmids containing an
ori15A origin of replication is shown in Fig. 1. The
heterologous antigen cassette of the basic expression vector pGEN91 is
composed of individual cassettes encoding an inducible promoter to
control transcription of the heterologous antigen cassette, which for
the work presented here encodes the test antigen GFPuv. Components of a
plasmid maintenance system were then systematically inserted into
pGEN91 to assess any individual or synergistic influence of these
functions on plasmid stability in the presence and absence of
selection. A complete plasmid maintenance system will be defined here
as being composed of a postsegregational killing function and both a
passive and an active plasmid-partitioning function. For the expression
plasmids reported here, the postsegregational killing function is
represented by the hok-sok locus; this locus was inserted
into pGEN91 to create pGEN111 and ensure that flanking transcription
from surrounding loci, such as the antigen and selection cassettes, was
divergent and would not significantly disturb the wild-type
transcription levels which control the lethality of this locus. We also
examined the effects of both passive and active partitioning loci on
expression plasmid stability and synthesis of GFPuv. We inserted the
par passive partition locus between the origin of
replication and selection cassettes (Fig. 1, pGEN121). Interestingly,
it was noted that the orientation of the par locus enhanced
synthesis of GFPuv on solid medium when inserted in the natural
orientation found within ori101 of pSC101, and this
orientation was adopted for all of the expression plasmids. The active
partitioning locus chosen for this work was the parA locus
from the same pR1 resistance plasmid from which hok-sok was
adapted; it was expected that the compatibility of these two loci
within pR1 would be maintained within our expression plasmids. Again,
to preserve natural transcription levels and regulation within this
locus, the cassette was positioned within an area of the expression
plasmids such that flanking transcription progressed away from
parA (Fig. 1, pGEN193 and pGEN222).
Osmotic control of PompC.
It was intended
that any promoter controlling transcription of a heterologous gene be
responsive to an environmental signal of biological relevance. For the
expression plasmids described here, an ompC promoter
cassette (PompC) from E. coli was
used, which is induced by increases in osmolarity. Construction of this
cassette was based on the sequence of PompC
published by Norioka et al. (37) and was engineered to
control expression of a test antigen cassette containing the
gfpuv allele encoding GFPuv; this
PompC-gfpuv cassette was inserted into a derivative of pBR322 to create pGFPompC. During the visual
screening of E. coli DH5
(pGFPompC) colonies
subilluminated with UV light, one very brightly fluorescing colony and
another representative fluorescent colony were chosen for further
study, designated clones 1 and 3, respectively. Upon purification of
the plasmids involved, it was determined that clone 1 contained a
plasmid that no longer carried a BglII site separating
PompC and gfpuv, while clone 3 carried the expected BglII site. We examined the induction of GFPuv expression when clones 1 and 3 were grown on nutrient agar in
the presence or absence of NaCl and determined by visual inspection
that clone 3 displayed very little fluorescence when grown in the
absence of NaCl but fluoresced brightly when plated on medium
containing 300 mM NaCl (data not shown). Clone 1, however, had a higher
background level of fluorescence when uninduced, but fluoresced
intensely when induced with 300 mM NaCl. To rule out mutations within
the gfpuv gene which might affect fluorescence, we replaced
PompC from clone 1 with
PompC from clone 3 and confirmed the expected
decrease in fluorescence as judged by subillumination (data not shown).
We therefore concluded that differences in observed fluorescence were
controlled by two genetically distinct versions of the
PompC promoter, which we designate as
PompC1 (higher transcription levels with less
osmotic control) and PompC3 (moderate
transcription levels but more responsive to osmolarity); we have
designated the plasmids containing these expression cassettes as
pGFPompC1 and pGFPompC3, respectively.
and S. typhi CVD
908-htrA by flow cytometry. This powerful technique has the
unique advantage of allowing rapid measurement of GFPuv expression
within large numbers of individual bacteria, as well as accurately
determining the intensity of fluorescence due to GFPuv synthesis within
each bacterium analyzed. As summarized in Table
3, the basal level of expression for the
PompC1-gfpuv cassette is 2.5-fold higher than
that for the PompC3-gfpuv cassette, when
expressed in DH5
, and 2.1-fold higher when expressed within CVD
908-htrA; however, the basal level of fluorescence detected
for synthesis of GFPuv never exceeded a mean fluorescent intensity of
5.4, regardless of host background. If we define the induction ratio as
the ratio of mean fluorescent intensity measured after induction
divided by the basal level of mean fluorescent intensity, it was
observed that when induced with 150 mM NaCl, PompC1 and PompC3
displayed within DH5
induction ratios of 1.7 and 2.4, respectively.
Surprisingly, the induction ratio for PompC1
when measured in CVD 908-htrA was 4.4, and
PompC1 produced a maximum mean fluorescence
intensity of 23.4 for these experiments. Although the induction ratio
for PompC3 within CVD 908-htrA was
6.7, the mean fluorescence intensity of 17.1 was lower than that
measured for PompC1.
|
Stability of expression plasmids in the absence of selection. Since the broad objective of the research presented here is to develop a noncatalytic plasmid maintenance system to enhance the stability of multicopy expression plasmids encoding foreign antigens within CVD 908-htrA, we initiated experiments to monitor plasmid stability by quantitating expression of GFPuv by flow cytometry when strains were passaged in the absence of antibiotic selection. These experiments were designed to address three fundamental questions. (i) What is the effect of copy number on the stability of plasmids expressing GFPuv? (ii) What is the effect of the induction level of PompC1 on the stability of plasmids encoding a heterologous antigen such as GFPuv? (iii) How do the hok-sok, par, and parA maintenance functions affect plasmid retention, both as individual components and synergistically?
Initial flow cytometry experiments were carried out in which CVD 908-htrA carried isogenic replicons with various maintenance functions and either the oriE1 or ori15A origin of replication. (Figure 1 depicts the isogenic series of ori15A replicons.) It was quickly determined that replicons carrying the higher-copy-number oriE1 origins with maintenance functions were very unstable, even when strains were grown in the presence of antibiotic selection. Flow cytometry results indicated that even when cultured in the presence of carbenicillin, the percentage of the bacterial populations no longer expressing detectable GFPuv ranged from approximately 50% for constructs carrying either hok-sok or hok-sok plus par to 62% for constructs with hok-sok plus par plus parA. Since replicons carrying an oriE1 origin clearly did not allow for optimal synthesis of the heterologous GFPuv test antigen within the majority of a growing population of live-vector bacteria, this series of expression plasmids was not examined further. Maintenance of expression plasmids containing an ori15A origin of replication was then examined. Results for CVD 908-htrA harboring a particular expression plasmid and passaged for 24 h in the absence of selection are listed in Table 4; histograms representing these data are shown in Fig. 2. In general, as osmolarity increased and induction of PompC1 rose, the percentage of the live-vector population expressing GFPuv decreased; nevertheless, the mean level of fluorescence intensity increased as expected. For example, in the presence of 50 mM NaCl, 80.5% of a population of CVD 908-htrA(pGEN121) expressed GFPuv with a mean fluorescence intensity of 53.3; as the concentration of NaCl increased to 300 mM, only 56.7% of the population expressed GFPuv, but the mean fluorescence intensity jumped to 105.3. However, it is notable that for strains carrying pGEN222 with a complete plasmid maintenance system (i.e., hok-sok plus par plus parA), the percentage of the population expressing the heterologous antigen remained at approximately 95% regardless of induction, while the mean fluorescence intensity increased from 52.1 (50 mM NaCl) to 89.2 (300 mM NaCl). It was noted that upon passage of these strains for an additional 24 h in the absence of antibiotic selection, less than 5% of bacteria continued to express functional GFPuv. Streaks of these cultures onto solid medium, prior to flow analysis, indicated that nonfluorescing bacteria remained viable; this was confirmed when nonfluorescing bacteria were sorted and shown by plating to be sensitive to antibiotic and nonfluorescing when irradiated with UV light, indicating loss of resident plasmids.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The broad objective of the research presented here is to develop a plasmid maintenance system for the stabilization of multicopy expression plasmids encoding foreign antigens in an S. typhi live-vector vaccine strain, without additional modification of the chromosome. Attempts were made to enhance the maintenance of expression plasmids at two independent levels. First, dependence upon balanced-lethal maintenance systems that involve catalytic enzymes expressed from multicopy plasmids was removed; this was accomplished through incorporation into expression plasmids of a postsegregational killing system based on the noncatalytic hok-sok plasmid addiction system from the antibiotic resistance factor pR1. At least one naturally occurring plasmid partition function was also introduced into these expression plasmids, to potentially eliminate random segregation of such plasmids, thereby enhancing their inheritance and stability.
Although these expression plasmids are ultimately intended to express immunogenic and protective antigens for delivery to the human immune system, GFPuv was selected as a test reporter antigen, because quantitation of mean fluorescence in a population of growing live vectors could be used as a measure of the stability of resident plasmids within the live vector. All expression plasmids carried an identical antigen expression cassette, with a PompC1 allele controlling transcription and with translation optimized by incorporation of a consensus ribosome binding site. Because no catalytic activity is associated with the fluorescence of GFPuv, the level of fluorescence intensity measured by flow cytometry within individual bacteria could be correlated directly with gene dosage and copy number. In addition, use of an osmotically regulated ompC promoter allowed an assessment of plasmid stability and live-vector viability as increasing osmolarity induced higher levels of GFPuv synthesis and presumably higher levels of metabolic stress on the live vector. It was surprising and encouraging that although the PompC1 allele was engineered from the chromosomal locus of E. coli, it appeared to function more efficiently in S. typhi (Table 3).
The contributions of several plasmid maintenance functions to the stability of plasmids within CVD 908-htrA, growing in the absence of antibiotic selection, were examined. No combination of maintenance functions could stabilize plasmids containing oriE1 origins of replication; in fact, constructs containing maintenance functions were difficult to propagate even in the presence of antibiotic. These observations cast doubt upon the rationale for using higher-copy-number plasmids to optimize expression of heterologous antigens within the cytoplasm of S. typhi-based live vectors, a strategy that heretofore has been followed by other groups investigating salmonellae as live vectors (12).
Incorporation of plasmid maintenance functions into plasmids carrying an ori15A origin of replication was more encouraging. When live vectors carrying such plasmids were passaged without selection for 24 h at 37°C, the effects of various combinations of maintenance functions became apparent. In the absence of maintenance functions, the ori15A replicon pGEN91 was lost from greater than 85% of the population, regardless of the level of induction of PompC1 (Table 4 and Fig. 2). With incorporation of the hok-sok postsegregational killing locus in pGEN111, the percentage of bacteria expressing GFPuv tripled under all induction conditions, confirming the observations of others that the hok-sok locus enhances the stability of ori15A replicons (18, 20, 21). However, it was still noted that regardless of induction conditions, greater than 50% of the bacterial population no longer fluoresced. Since it was confirmed that at least a portion of this nonfluorescing population was still viable and lacked drug resistance, these data confirm previous reports (22, 39, 53) that the presence of a hok-sok postsegregational killing system is insufficient by itself to ensure that plasmidless viable bacteria will not arise in a growing population.
One possible mechanism that allows for escape from the influence of hok-sok involves spontaneous point mutations arising within the lethal Hok ORF, which could conformationally inactivate Hok and thereby allow plasmid loss to occur without lethality. This point emphasizes the requirement of multiple mechanisms for enhancing the stability of resident plasmids within growing bacteria; should one maintenance function become inactivated, the probability of other independent functions simultaneously becoming inactivated becomes vanishingly small. Indeed, such redundancy in maintenance functions is widespread within naturally occurring low-copy-number plasmids (36). For example, the E. coli sex factor F contains one active partitioning function (sop) and two killing systems (ccd and flm) (23, 29, 35, 51). Similarly, the drug resistance plasmid pR1 contains the active partitioning function parA, as well as the postsegregational killing system hok-sok; in addition, it carries yet another recently defined kis-kid killing system (7, 8, 41). We have demonstrated in the work reported here that insertion into multicopy ori15A replicons of a more complete maintenance system, composed of both a postsegregational system and two partition functions, dramatically improves the stability of these expression plasmids in the absence of selection, regardless of induction conditions for heterologous antigen expression. However, after passage without selection for 48 h, plasmids were eventually lost from the bacterial population, possibly due to escape from the lethality of Hok. This problem has recently been addressed by Pecota et al. (39), who reported that incorporation of dual killing systems significantly improved plasmid stability compared to the use of hok-sok alone; no partition functions were present in these plasmids. Perhaps inclusion of the kis-kid killing system, to more fully represent the complement of pR1 stability functions, may be required for optimal stability of higher-copy expression plasmids within S. typhi live vectors.
The efficiency of eliciting an immune response directed against a heterologous antigen will depend in part upon the ability of the live vector to present such antigens to the immune system. The ability of a live vector to present antigens will in turn depend upon the stability of multicopy expression plasmids that encode the heterologous antigens. However, we hypothesize that a significant metabolic burden is placed upon CVD 908-htrA carrying a multicopy expression plasmid; as copy number and/or level of gene expression increases, metabolic burden increases. Studies with E. coli have clearly established that plasmid-bearing bacteria grow more slowly than plasmidless bacteria (6, 30, 39, 46, 53). It has also been demonstrated that as copy number increases, the growth rate of such strains decreases; similarly, as induction of heterologous genes increases, growth rate decreases further (39, 53). Clearly, spontaneous plasmid loss would remove any metabolic burden and allow plasmidless bacteria to quickly outgrow the population of plasmid-bearing bacteria. Such a shift in antigen expression within a population of live-vector bacteria would be expected to reduce the efficiency of stimulating any immune response specific to the foreign antigen. Such reasoning suggests that the goal for an effective multivalent S. typhi-based live vector vaccine is to optimize viability by using stabilized lower-copy-number expression plasmids, capable of expressing high levels of heterologous antigen in response to an environmental signal likely to be encountered in vivo after the vaccine organisms have reached an appropriate ecological niche. We are currently testing this strategy by using the murine intranasal model to examine the immunogenicity of protein fusions involving fragment C of tetanus toxin fused at the carboxyl terminus to antigens from the malaria agent Plasmodium falciparum, expressed within CVD 908-htrA by using expression plasmids derived from pGEN222. It is hoped that such experiments will point the way toward development of single-dose, oral S. typhi-based live-vector vaccines capable of inducing protective immune responses against multiple unrelated human pathogens.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by grants 5 RO1 AI29471, RO1 AI40297, and Research contract NO1 AI45251 (M. M. Levine, principal investigator).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201. Phone: (410) 706-5328. Fax: (410) 706-6205. E-mail: jgalen{at}umppa1.ab.umd.edu.
This work is dedicated to the memory of James F. Galen, Jr.
Present address: Pediatric House Staff, Vanderbilt University
Hospital, Nashville, TN 37232-7530.
§ Present address: University of Louisville ICT, Louisville, KY 40202.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Austin, S.,
S. Friedman, and D. Ludtke.
1986.
Partition functions of unit-copy plasmids can stabilize the maintenance of plasmid pBR322 at low copy number.
J. Bacteriol.
168:1010-1013 |
| 2. |
Balbas, P.,
X. Soberon,
E. Merino,
M. Zurita,
H. Lomeli,
F. Valle,
N. Flores, and F. Bolivar.
1986.
Plasmid vector pBR322 and its special-purpose derivatives a review.
Gene
50:3-40[Medline].
|
| 3. | Barry, E. M., O. Gomez-Duarte, S. Chatfield, R. Rappuoli, M. Pizza, G. Losonsky, J. Galen, and M. M. Levine. 1996. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect. Immun. 64:4172-4181[Abstract]. |
| 4. | Beaucage, S. L., C. A. Miller, and S. N. Cohen. 1991. Gyrase-dependent stabilization of pSC101 plasmid inheritance by transcriptionally active promoters. EMBO J. 10:2583-2588[Medline]. |
| 5. | Blomfield, I. C., V. Vaughn, R. F. Rest, and B. I. Eisenstein. 1991. Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol. Microbiol. 5:1447-1457[Medline]. |
| 6. |
Boe, L.,
K. Gerdes, and S. Molin.
1987.
Effects of genes exerting growth inhibition and plasmid stability on plasmid maintenance.
J. Bacteriol.
169:4646-4650 |
| 7. | Bravo, A., G. de Torrontegui, and R. Diaz. 1987. Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid. Mol. Gen. Genet. 210:101-110[Medline]. |
| 8. | Bravo, A., S. Ortega, G. de Torrontegui, and R. Diaz. 1988. Killing of Escherichia coli cells modulated by components of the stability system parD of plasmid R1. Mol. Gen. Genet. 215:146-151[Medline]. |
| 9. | Brosius, J. 1989. Superpolylinkers in cloning and expression vectors. DNA 8:759-777[Medline]. |
| 10. |
Chang, A. C. Y., and S. N. Cohen.
1978.
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.
J. Bacteriol.
134:1141-1156 |
| 11. | Covarrubias, L., L. Cervantes, A. Covarrubias, X. Soberon, I. Vichido, A. Blanco, Y. M. Kupersztoch-Portnoy, and F. Bolivar. 1981. Construction and characterization of new cloning vehicles. V. Mobilization and coding properties of pBR322 and several deletion derivatives including pBR327 and pBR328. Gene 13:25-35[Medline]. |
| 12. |
Covone, M. G.,
M. Brocchi,
E. Palla,
W. D. da Silveira,
R. Rappuoli, and C. L. Galeotti.
1998.
Levels of expression and immunogenicity of attenuated Salmonella enterica serovar Typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin.
Infect. Immun.
66:224-231 |
| 13. | Crameri, A., E. A. Whitehorn, E. Tate, and W. P. Stemmer. 1996. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat. Biotechnol. 14:315-319[Medline]. |
| 14. | Dam, M., and K. Gerdes. 1994. Partitioning of plasmid R1: ten direct repeats flanking the parA promoter constitute a centromere-like partition site parC, that expresses incompatibility. J. Mol. Biol. 236:1289-1298[Medline]. |
| 15. | Galen, J. E., K. Nakayama, and R. Curtiss, III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35[Medline]. |
| 16. | Galen, J. E., O. G. Gomez-Duarte, G. Losonsky, J. L. Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708[Medline]. |
| 17. | Galen, J. E., E. R. Vimr, L. Lawrisuk, and J. B. Kaper. 1990. Cloning, sequencing, and expression of the gene, nanH, for Vibrio cholerae neuraminidase, p. 143-153. In R. B. Sack, and Y. Zinnake (ed.), Advances in research on cholera and related diarrheas. KTK Scientific Publishers, Tokyo, Japan. |
| 18. | Gerdes, K. 1988. The parB (hok/sok) locus of plasmid R1: a general purpose plasmid stabilization system. Bio/Technology 6:1402-1405. |
| 19. | Gerdes, K., A. P. Gultyaev, T. Franch, K. Pedersen, and N. D. Mikkelsen. 1997. Antisense RNA-regulated programmed cell death. Annu. Rev. Genet. 31:1-31[Medline]. |
| 20. | Gerdes, K., J. S. Jacobsen, and T. Franch. 1997. Plasmid stabilization by post-segregational killing. Genet. Eng. 19:49-61. |
| 21. |
Gerdes, K.,
J. E. Løve Larsen, and S. Molin.
1985.
Stable inheritance of plasmid R1 requires two different loci.
J. Bacteriol.
161:292-298 |
| 22. |
Gerdes, K.,
P. B. Rasmussen, and S. Molin.
1986.
Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells.
Proc. Natl. Acad. Sci. USA
83:3116-3120 |
| 23. | Golub, E. I., and H. A. Panzer. 1988. The F factor of Escherichia coli carries a locus of stable plasmid inheritance stm, similar to the parB locus of plasmid R1. Mol. Gen. Genet. 214:353-357[Medline]. |
| 24. | Gultyaev, A. P., T. Franch, and K. Gerdes. 1997. Programmed cell death by hok/sok of plasmid R1: coupled nucleotide covariations reveal a phylogenetically conserved folding pathway in the hok family of mRNAs. J. Mol. Biol. 273:26-37[Medline]. |
| 25. | Hiszczynska-Sawicka, E., and J. Kur. 1997. Effect of Escherichia coli IHF mutations on plasmid p15A copy number. Plasmid 38:174-179[Medline]. |
| 26. | Hone, D. M., A. M. Harris, S. Chatfield, G. Dougan, and M. M. Levine. 1991. Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9:810-816[Medline]. |
| 27. | Jensen, R. B., and K. Gerdes. 1997. Partitioning of plasmid R1. The ParM protein exhibits ATPase activity and interacts with the centromere-like ParR-parC complex. J. Mol. Biol. 269:505-513[Medline]. |
| 28. | Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rouse. 1995. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563[Abstract]. |
| 29. | Loh, S. M., D. S. Cram, and R. A. Skurray. 1988. Nucleotide sequence and transcriptional analysis of a third function (Flm) involved in F plasmid maintenance. Gene 66:259-268[Medline]. |
| 30. | McDermott, P. J., P. Gowland, and P. C. Gowland. 1993. Adaptation of Escherichia coli growth rates to the presence of pBR322. Lett. Appl. Microbiol. 17:139-143[Medline]. |
| 31. | Meacock, P. A., and S. N. Cohen. 1980. Partitioning of bacterial plasmids during cell division: a cis-acting locus that accomplishes stable plasmid inheritance. Cell 20:529-542[Medline]. |
| 32. | Miller, C. A., S. L. Beaucage, and S. N. Cohen. 1990. Role of DNA superhelicity in partitioning of the pSC101 plasmid. Cell 62:127-133[Medline]. |
| 33. | Miller, C. A., W. T. Tucker, P. A. Meacock, P. Gustafsson, and S. N. Cohen. 1983. Nucleotide sequence of the partition locus of Escherichia coli plasmid pSC101. Gene 24:309-315[Medline]. |
| 34. | Nakayama, K., S. M. Kelley, and R. Curtiss, III. 1988. Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697. |
| 35. | Niki, H., and S. Hiraga. 1997. Subcellular distribution of actively partitioning F plasmid during the cell division cycle of E. coli. Cell 90:951-957[Medline]. |
| 36. | Nordstrom, K., and S. J. Austin. 1989. Mechanisms that contribute to the stable segregation of plasmids. Annu. Rev. Genet. 23:37-69[Medline]. |
| 37. |
Norioka, S.,
G. Ramakrishnan,
K. Ikenaka, and M. Inouye.
1986.
Interaction of a transcriptional activator, OmpR, with reciprocally osmoregulated genes, ompF and ompC, of Escherichia coli.
J. Biol. Chem.
261:17113-17119 |
| 38. |
Oxer, M. D.,
C. M. Bentley,
J. G. Doyle,
T. C. Peakman,
I. G. Charles, and A. J. Makoff.
1991.
High level heterologous expression in E. coli using the anaerobically-activated nirB promoter.
Nucleic Acids Res.
19:2889-2892 |
| 39. | Pecota, D. C., C. S. Kim, K. Wu, K. Gerdes, and T. K. Wood. 1997. Combining the hok/sok, parDE, and pnd postsegregational killer loci to enhance plasmid stability. Appl. Environ. Microbiol. 63:1917-1924[Abstract]. |
| 40. | Puente, J. L., A. Verdugo-Rodriguez, and E. Calva. 1991. Expression of Salmonella typhi and Escherichia coli OmpC is influenced differently by medium osmolarity; dependence on Escherichia coli OmpR. Mol. Microbiol. 5:1205-1210[Medline]. |
| 41. | Ruiz-Echevarria, M. J., G. Gimenez-Gallego, R. Sabariegos-Jareno, and R. Diaz-Orejas. 1995. Kid, a small protein of the parD stability system of plasmid R1, is an inhibitor of DNA replication acting at the initiation of DNA synthesis. J. Mol. Biol. 247:568-577[Medline]. |
| 42. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 43. | Selzer, G., T. Som, T. Itoh, and J. Tomizawa. 1983. The origin of replication of plasmid p15A and comparative studies on the nucleotide sequences around the origin of related plasmids. Cell 32:119-129[Medline]. |
| 44. |
Shaw, K. J.,
P. N. Rather,
R. S. Hare, and G. H. Miller.
1993.
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
Microbiol. Rev.
57:138-163 |
| 45. | Srinivasan, J., S. A. Tinge, R. Wright, J. C. Herr, and R. Curtiss, III. 1995. Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biol. Reprod. 53:462-471[Abstract]. |
| 46. | Summers, D. K. 1998. Timing, self-control and sense of direction are the secrets of multicopy plasmid stability. Mol. Microbiol. 29:1137-1145[Medline]. |
| 47. | Tacket, C. O., S. M. Kelley, F. Schödel, G. Losonsky, J. P. Nataro, R. Edelman, M. M. Levine, and R. Curtiss, III. 1997. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. Infect. Immun. 65:3381-3385[Abstract]. |
| 48. | Tacket, C. O., M. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune responses in humans. Infect. Immun. 65:452-456[Abstract]. |
| 49. |
Tartera, C., and E. S. Metcalf.
1993.
Osmolarity and growth phase overlap in regulation of Salmonella typhi adherence to and invasion of human intestinal cells.
Infect. Immun.
61:3084-3089 |
| 50. | Twigg, A. J., and D. Sherratt. 1980. Trans-complementable copy-number mutants of plasmid ColE1. Nature 283:216-218[Medline]. |
| 51. | Van Melderen, L., P. Bernard, and M. Couturier. 1994. Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol. Microbiol. 11:1151-1157[Medline]. |
| 52. | Wahle, E., and A. Kornberg. 1988. The partition locus of plasmid pSC101 is a specific binding site for DNA gyrase. EMBO J. 7:1889-1895[Medline]. |
| 53. | Wu, K., and T. K. Wood. 1994. Evaluation of the hok/sok killer locus for enhanced plasmid stability. Biotechnol. Bioeng. 44:912-921. |
| 54. | Zurita, M., F. Bolivar, and X. Soberon. 1984. Construction and characterization of new cloning vehicles. VII. Construction of plasmid pBR327par, a completely sequenced, stable derivative of pBR327 containing the par locus of pSC101. Gene 28:119-122[Medline]. |
This article has been cited by other articles: